When Global ART Budgets Cannot Cover All Patients, Who Should Be Eligible?

Area of Science:

• Public Health
• Medical Ethics
• Global Health Policy

Background:

• Global HIV/AIDS response budgets face expected cuts, necessitating difficult prioritization decisions.
• Limited funding requires strategic allocation of resources for maximum impact.

Purpose of the Study:

• To evaluate antiretroviral therapy (ART) eligibility policies using ethical frameworks.
• To compare the ethical implications of earlier versus later ART eligibility.

Main Methods:

• Comparative analysis of ART eligibility policies.
• Assessment based on life-years saved, quality-adjusted life-years, and ethical considerations for different patient groups.
• Ethical evaluation through multiple theoretical lenses.

Main Results:

• Prioritizing ART for sicker patients, rather than immediate universal access, maximizes life-years saved and benefits the most vulnerable.
• This approach aligns with several key ethical considerations, including prioritizing the sickest and those with the greatest need.
• The strategy is deemed 'cross-theoretically dominant' in ethical evaluations.

Conclusions:

• In resource-limited settings with generalized HIV/AIDS epidemics, reserving ART for sicker individuals is ethically superior to current international standards.
• This prioritization strategy offers a more ethical approach to ART allocation under financial constraints.
• The findings support a shift in policy to focus on the most critically ill patients first.